Eva Temkin to Interview M. Stacey Ricci About Biosimilars and Interchangeable Products

Washington, D.C., Government Matters partner Eva Temkin will interview M. Stacey Ricci, Director of the Scientific Review Staff in the Office of Therapeutic Biologics and Biosimilars from the U.S. Food and Drug Administration on June 28. The topic will be “Biosimilars and Interchangeable Products: Insights into FDA’s Perspective on Implementation.” More information will be found here.